You are here: Home
 
Banner
Regional variations in US cancer imaging data: a warning for imaging overuse

Regional variations in US cancer imaging data: a warning for imaging overuse

Danil V Makarov speaks to Gemma Westcott, Commissioning Editor: Danil V Makarov is an Assistant Professor and Director of Surgical Research in the Department o...

SABCS15: ONT-380 Phase I results support progression to Phase II in advanced HER2+ breast cancer

SABCS15: ONT-380 Phase I results support progression to Phase II in advanced HER2+ breast cancer

Phase I data regarding the experimental cancer agent ONT-380 were presented recently at the 2015 San Antonio Breast Cancer Symposium, indicating initial effi...

New Directions in Breast Conserving Surgery – An Interview with Pat Whitworth, MD and Frank Vicini, MD

New Directions in Breast Conserving Surgery – An Interview with Pat Whitworth, MD and Frank Vicini, MD

In this interview, Pat Whitworth, MD, Breast Surgical Oncologist and Director of the Nashville Breast Center in Tennessee (USA), discusses recent advances in...

Banner

Knowledge Bank

Edit

Amount of short articles:

Amount of articles links:

You can order sections with dragging on list bellow:

  • Knowledge Bank
Save
Cancel
Reset

News

AstraZeneca enters into US licensing agreement with Ironwood Pharmaceuticals for

AstraZeneca announced that it has entered into a licensing agreement with Ironwood Pharmaceuticals for the exclusive US rights to Zurampic® (lesinurad). Zurampic was approved by the US Food and Drug

Tuesday, 26 April 2016 Comments

Press Releases

European Medicines Agency Issues Positive Opinion for the Use of IMBRUVICA®

AbbVie, a global biopharmaceutical company, announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) issued a positive opinion in favor of the

Friday, 29 April 2016 Comments

Research Insight

IMS Health Study: U.S. Drug Spending Growth Reaches 8.5 Percent in

Total spending on medicines in the U.S. reached $310 billion in 2015 on an estimated net price basis, up 8.5 percent from the previous year, according to a new report

Thursday, 14 April 2016 Comments

Techno Trends

McKesson Launches NEW Drug Spend Intelligence

McKesson announced the launch of its new Drug Spend Intelligence™ tool. Designed by hospital pharmacists, Drug Spend Intelligence is an easy-to-use online tool that provides the information needed to identify

Tuesday, 1 March 2016 Comments

Industry Reports

INNATE PHARMA IN-LICENSES OREGA BIOTECH'S FIRST-IN-CLASS ANTI-CD39 CHECKPOINT INHIBITOR

This program, currently in preclinical development, aims at developing an anti-CD39 mAb; Targeting the adenosine immunosuppressive pathway has potential to promote anti-tumor immune responses across a wide range of tumors; Anti-CD39 broadens In

Thursday, 28 January 2016 Comments

Articles

Gastroesophageal Reflux Disease (GERD or

Gastroesophageal Reflux Disease is a condition resulting from stomach acid moving backward from the stomach into the esophagus (the tube that connects the mouth to the stomach). The acid causes

Tuesday, 9 February 2016 Comments

Banner